![Clemens M. Doppler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clemens M. Doppler
Président chez
4SC AG
Profil
Clemens M.
Doppler is currently Chairman-Supervisory Board at 4SC AG since 2014, Chairman at MerLion Pharmaceuticals Pte Ltd. since 2006, Chairman-Supervisory Board at MerLion Pharmaceuticals GmbH, Chairman at 3i Private Equity, Managing Director at Heidelbergcapital General Partner GmbH since 2008, Managing Partner at HeidelbergCapital Asset Management GmbH since 2008, Member at DVFA e.V., and Member-Supervisory Board at Verinos Pharmaceuticals GmbH.
Former positions include Chairman at Accovion GmbH from 2008 to 2015, Vice Chairman-Supervisory Board at Sensovation AG from 2009 to 2013, Business Development Director & Head-department at Phoenix International Life Sciences, Inc. from 1994 to 2000, Director-Business Development & Head-department at Phoenix International Life Sciences, Inc. (Switzerland) from 1994 to 2000, Director at Merlion Trade GmbH, Investment Manager at 3i Group Plc from 2000 to 2007, Investment Manager at Technologie Holding, Member-Supervisory Board at vasopharm GmbH, and Member-Supervisory Board at Nanogate SE.
Education includes graduate and doctorate degrees from Ruprecht-Karls-Universität Heidelberg.
Postes actifs de Clemens M. Doppler
| Sociétés | Poste | Début |
|---|---|---|
| 4SC AG | Président | 19/09/2014 |
MerLion Pharmaceuticals GmbH
 MerLion Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences, engineering, agricultural sciences and medicine | Président | - |
Heidelbergcapital General Partner GmbH | Directeur Général | 01/01/2008 |
MerLion Pharmaceuticals Pte Ltd.
 MerLion Pharmaceuticals Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics | Président | 01/01/2006 |
DVFA e.V. | Corporate Officer/Principal | - |
HeidelbergCapital Asset Management GmbH
 HeidelbergCapital Asset Management GmbH Investment ManagersFinance HCAM is a private equity investment manager specializing in secondary direct investments. They acquire portfolios of minority shareholdings from private equity and venture capital firms as well as investment banks. Their targeted range of investments includes early-stage companies which are already past the startup-phase and have a proven business model, as well as established medium-sized family-owned businesses and small-cap listed companies. They may consider investing in a single company on a case-by-case basis. They are active partners for their portfolio companies, and get involved in strategic decisions. Their strategy includes investing growth capital in the companies in which they have acquired a stake. | Private Equity Investor | 01/01/2008 |
3i Private Equity
 3i Private Equity Investment ManagersFinance 3i Private Equity invests in middle market companies located in Europe and North America with an enterprise value of EUR 100 - 500 million. The firm targets companies operating in the fields of consumer & private label, healthcare, industrial, services and software sectors. It provides financing for buyout and growth stage capital requirements also acquires majority and minority interest and also makes co-investments. | Private Equity Investor | - |
Anciens postes connus de Clemens M. Doppler
| Sociétés | Poste | Fin |
|---|---|---|
Merlion Trade GmbH | Directeur/Membre du Conseil | 23/01/2021 |
Accovion GmbH
 Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Président | 01/01/2015 |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Clemens M. Doppler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Phoenix International Life Sciences, Inc.
 Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioanalytical research and clinical testing services | Commercial Services |
3i Group Plc
 3i Group Plc Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Technologie Holding
 Technologie Holding Financial ConglomeratesFinance Provides Internet investment services | Finance |
Accovion GmbH
Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensovation AG
 Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets scientific imaging instrumentation technologies | Electronic Technology |
MerLion Pharmaceuticals Pte Ltd.
MerLion Pharmaceuticals Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics | Health Technology |
Nanogate SE
 Nanogate SE Industrial MachineryProducer Manufacturing Designs, develops and produces composite and surface treatments | Producer Manufacturing |
3i Private Equity
3i Private Equity Investment ManagersFinance 3i Private Equity invests in middle market companies located in Europe and North America with an enterprise value of EUR 100 - 500 million. The firm targets companies operating in the fields of consumer & private label, healthcare, industrial, services and software sectors. It provides financing for buyout and growth stage capital requirements also acquires majority and minority interest and also makes co-investments. | Finance |
HeidelbergCapital Asset Management GmbH
HeidelbergCapital Asset Management GmbH Investment ManagersFinance HCAM is a private equity investment manager specializing in secondary direct investments. They acquire portfolios of minority shareholdings from private equity and venture capital firms as well as investment banks. Their targeted range of investments includes early-stage companies which are already past the startup-phase and have a proven business model, as well as established medium-sized family-owned businesses and small-cap listed companies. They may consider investing in a single company on a case-by-case basis. They are active partners for their portfolio companies, and get involved in strategic decisions. Their strategy includes investing growth capital in the companies in which they have acquired a stake. | Finance |
Merlion Trade GmbH | |
DVFA e.V. | |
MerLion Pharmaceuticals GmbH
MerLion Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences, engineering, agricultural sciences and medicine | Commercial Services |
Heidelbergcapital General Partner GmbH | |
Phoenix International Life Sciences,Inc. (Switzerland) |
Choisissez Zonebourse 
